Abbott to Acquire Exact Sciences in a $21 Billion Deal, Boosting Cancer Diagnostics Push Nov 20, 2025 Life Science
Acquisition Rumors Drive Exact Sciences Stock Price Surge, Market Watches Potential Deal Progress Nov 19, 2025 Life Science
With Capital and Policy Working in Tandem, Biotechnology ETFs Present a Strategic Investment Opportunity Nov 17, 2025 Life Science
Trump Strikes Deal with Lilly and Novo Nordisk, Slashing Prices of Weight-Loss Drugs Nov 16, 2025 Life Science
Amgen’s Strong Q3 Performance and Multi-Faceted Strategy Drive Long-Term Value Nov 11, 2025 Life Science
GLP-1 Price Cut Storm: Lilly and Novo Nordisk Engage in Strategic “Volume-for-Value” Game Nov 10, 2025 Life Science
AstraZeneca Soars on Positive Trial Results for Hypertension Drug and Strong Earnings Nov 10, 2025 Life Science
Metsera’s Impressive Clinical Data for Weight-Loss Drug Sparks Bidding War Among Pharma Giants Nov 6, 2025 Life Science
U.S. Government Facilitates Historic Price Cut for Weight-Loss Drugs, with an Agreed Price of $245 Nov 6, 2025 Life Science
Beyond the Tech Titans: An AI Stock With a Different Kind of Disruption Nov 4, 2025 Life Science, Technology
Experiments, Mergers, and Interest Rate Cuts: The Biotechnology Sector Ushers in a New Cycle Nov 4, 2025 Life Science
Metsera’s Weight-Loss Drug Technology Sparks Bidding War Among Giants as Stock Price Quadruples in a Month Nov 4, 2025 Life Science
